Novo Nordisk A/S
לונג
מעודכן

$NVO expected have better second half (H2)

1 087
- Potential Inverse H&S on daily?
- In the worst case, NVO goes to 200 monthly moving average around $36
- Nonetheless, We are bottoming fundamentally only question is how fast the turn around gonna be.
הערה
- I had a very big position starting this year and but sold pre-earning when they unprofessionally released earnings on breakeven.

- I have bought back around 43.xx but not gonna build a massive position this time because I am afraid that turn around might be slower.
הערה
- There are blood in the streets so I want to build bigger position in other companies where turn around could be faster. However, I am buying NVO for long term as weightloss and well being is multi year secular trend
הערה
- NVO will still have better second half where it recovers.
- However, it's clear LLY is a superior drug and NVO latest results confirm it
עסקה סגורה: הגיע לסטופ
הערה
pre-market $42 ; I believe this is heading to 200 day monthly moving average around $36 and then might find support or bottom based on fundamentals
הערה
pre-market $42 ; I believe this is heading to 200 day monthly moving average around $36 and then might find support or bottom based on fundamentals
הערה
NVO as I mentioned probably has bottomed around 200 day monthly average around 35-36 bucks

כתב ויתור

המידע והפרסומים אינם מיועדים להיות, ואינם מהווים, ייעוץ או המלצה פיננסית, השקעתית, מסחרית או מכל סוג אחר המסופקת או מאושרת על ידי TradingView. קרא עוד ב־תנאי השימוש.